Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population.
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2015
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms DESSIAN
- 16 Nov 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 22 Apr 2011 Planned End Date changed from 1 Apr 2011 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 22 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.